20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is EZETIMIBE USP, with a corresponding US DMF Number 31082.
Remarkably, this DMF maintains an Active status since its submission on December 08, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2017, and payment made on December 05, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II